Versameb CEO Klaas Zuideveld to present at RNA Leaders World Congress

Versameb CEO Klaas Zuideveld to present at RNA Leaders World Congress

Presentation demonstrates that lead therapeutic candidate VMB-100 has the potential to address the unmet medical needs of patients with stress urinary incontinence

March 10, 2022, Basel, Switzerland: Versameb AG (“Versameb”), a preclinical-stage company focused on the discovery and development of innovative RNA-based therapies, today announces that its management team will participate in the RNA Leaders World Congresstaking place on 16-17and March 2022 in Basel, Switzerland, where Chief Executive Officer Klaas Zuideveld will present data on the company’s mRNA engineering technology and its lead therapeutic candidate, VMB-100.

Versameb has developed a revolutionary proprietary technology platform that optimizes the application of functional RNA in different disease contexts. Its lead therapeutic candidate VMB-100 has demonstrated first-rate potential for the treatment of stress urinary incontinence (SUI) in a preclinical animal model showing regeneration and functional restoration of the urinary sphincter.

RNA World Leaders Congress

Dated: March 16-17, 2022, Palais des Congrès, Basel, Switzerland

Presentation by: Klaas Zuideveld, CEO, Versameb

Title: Urethral muscle regeneration in stress urinary incontinence using modified mRNA

Date and hour : wednesday 16and March 2022, 12:00 CET

Klaas Zuideveld, Managing Director, said: “We are excited to present data on our proprietary platform and core asset at the Global RNA Leaders Congress on the 16thand of March 2022. Our next-generation RNA platform has demonstrated pioneering potential for mRNA-based therapies in stress urinary incontinence and other indications. We are committed and working to bring our innovative technology to patients with SUI, an unmet medical need without approved restorative drug therapy.

Our understanding of RNA biology continues to mature. With this in mind, the first annual Global RNA Leaders Congress brings together more than 150 biotechnology, pharmaceutical, investment, regulatory and scientific professionals at the Global RNA Leaders Congress. Topics include the latest advances in RNA biology, updates from companies developing new therapies, and service partners who help deliver medicines to patients. Versameb are the bronze sponsors of the Congress.

If you would like to meet the Versameb team at the above event, please contact us using the details provided below. For more information, visit